RxSight, Inc. Deferred Revenue
RxSight, Inc. (RXST) had Deferred Revenue of $6.88 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2026-08-05
- 2026-06-30: Deferred Revenue $6.88M.
- 2025-06-30: Deferred Revenue $3.26M.
- 2023-09-30: Deferred Revenue $1.68B.
- 2023-06-30: Deferred Revenue $1.35B.
| Period end | Deferred Revenue | Deferred Revenue as first filed |
|---|---|---|
| 2026-06-30 | $6.88M 10-Q · filed 2026-08-05 | |
| 2025-06-30 | $3.26M 10-Q · filed 2026-08-05 | |
| 2023-09-30 | $1.68B 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.35B 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $1.39M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $1.19B 10-Q · filed 2023-11-09 | $1.19M 10-Q · filed 2023-05-09 |
| 2022-09-30 | $1.04B 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $738.00M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $622.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $540.00M 10-Q · filed 2022-11-07 | $540.00K 10-K · filed 2022-03-08 |
| 2021-09-30 | $449.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $380.00K 10-Q · filed 2021-09-09 | |
| 2020-12-31 | $345.00K 10-K · filed 2022-03-08 | |
| 2020-06-30 | $161.00K 10-Q · filed 2021-09-09 | |
| 2019-12-31 | $41.00K 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |